Uptrend on the daily chart: above its 50- and 200-day averages · 50-day below the 200-day · SuperTrend up since Dec 17 · inside the Ichimoku cloud · RSI 75 (overbought) · MACD below its signal
None of the 29 investors followed here reported a position in SRBCF in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a SRBCF trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for SRBCF.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% | ||
| 2025 | -14.2 | 15.7 | -58.8 | 0.7 | -77.0 | 2.3 | 312.5 | 17.4 | -46.0 | -10.4 | -99.0 | 5000.0 | −88.8% |
| 2024 | -18.8 | 2.5 | -28.1 | 8.6 | -27.3 | 0.0 | 0.0 | 37.8 | -2.5 | -21.5 | 39.5 | -18.3 | −43.1% |
| 2023 | -6.7 | -9.9 | 11.3 | 29.7 | 7.2 | -5.4 | -18.3 | -7.4 | 0.1 | -31.1 | 9.9 | 36.1 | −4.1% |
| 2022 | 9.8 | 0.1 | -6.5 | 4.6 | -5.8 | 30.0 | -22.4 | -10.4 | -12.9 | -23.1 | 25.9 | -26.4 | −43.3% |
| 2021 | 17.5 | -1.4 | 5.4 | -4.6 | -15.5 | -23.4 | -13.2 | -7.8 | 0.3 | -5.6 | 1.9 | -3.2 | −43.6% |
| 2020 | -7.5 | -26.5 | -3.1 | -15.9 | 28.8 | -20.8 | -9.8 | -10.1 | 34.2 | -10.1 | -14.2 | 62.9 | −22.8% |
| 2019 | 20.4 | 31.4 | 29.0 | 43.7 | 88.9 | 5.0 | -10.7 | 0.7 | -2.1 | 1.2 | -5.1 | 5.8 | +420.8% |
| 2018 | 26.5 | -4.5 | -29.1 | 1.0 | 3.9 | -11.9 | 1.4 | -25.9 | 26.4 | 11.8 | -5.9 | -8.1 | −27.1% |
| 2017 | 23.8 | -5.4 | -8.9 | -0.4 | 2.2 | 7.0 | 3.8 | -6.8 | 4.2 | -10.6 | 0.9 | -19.9 | −15.3% |
| 2016 | 29.0 | -5.0 | -1.7 | -4.4 | -8.2 | -2.0 | 3.9 | 9.1 | -10.4 | -5.5 | -1.5 | -19.2 | −20.9% |
| 2015 | -8.9 | 27.3 | -7.8 | -5.3 | -9.5 | 26.7 | 1.4 | -20.1 | 0.0 | 31.7 | -11.7 | 2.1 | +11.5% |
| 2014 | -7.6 | 12.6 | 47.1 | -14.8 | -21.3 | 14.0 | 4.4 | +22.2% |
No analyst coverage for this instrument.
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
No recent headlines.